Platelet Rich Plasma Market to Surpass US$ 1,129.4 Million by 2030, Says Coherent Market Insights (CMI)

Advertisement

Platelet Rich Plasma Therapy: Harnessing the Power of Regenerative Medicine

Burlingame, Feb. 27, 2023 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global platelet rich plasma market is estimated to be valued at US$ 442.7 million in 2022 and is expected to exhibit a CAGR of 12.4% during the forecast period (2022-2030).

Key Trends and Analysis of the Global Platelet Rich Plasma Market:

Advertisement

Major players operating in the market are focusing on product launches which is expected to drive the growth of global platelet rich plasma market over the forecast period. For instance, on September 13, 2022, SUNEVA MEDICAL, an innovative medical technology company, launched 30 mL iteration of their Amplifine Platelet Rich Plasma (PRP) gel tubes. This gel is designed to capture high concentration of platelets in low clearing time which will deliver clinical benefits to the patient.

Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/936

Platelet Rich Plasma Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2022: US$ 442.7 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2030
Forecast Period 2022 to 2030 CAGR: 12.4% 2030 Value Projection: US$ 1,129.4 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Type: Pure PRP, Leukocyte rich PRP, Pure PRF, Leukocyte rich PRF
  • By Origin: Autologous, Allogenic, Homologues
  • By Application: Neurosurgery, Cosmetic Surgery, Orthopedic Surgery, General Surgery, Others
Companies covered: Arthrex, Inc., Stryker Corporation, Johnson and Johnsons Ltd., Zimmer Biomet Holdings Inc., Terumo Corporation, Glofinn Oy, Medira Ltd., Regen Lab S.A., CollPlant, Generex Biotechnology Corporation, Estar Technologies Ltd., Dr. PRP America, Cesca Therapeutics, Inc., Arteriocyte Medical Systems, Harvest Technologies Corp.
Growth Drivers:
  • Increase in number cosmetic surgeries
  • High prevalence of sports injuries
Restraints & Challenges:
  • High cost of platelet rich plasma products

Key Market Takeaways:

The platelet rich plasma market is expected to exhibit a CAGR of 12.4% during the forecast period due to research & development in drug delivery system for platelet rich plasma-derived bioactive molecules. For instance, in September 2020, researchers from Institute of Experimental Medicine of the Czech Academy of Sciences and Charles University, Czech Republic, reported development of a simple delivery system to prolong the effects of the bioactive molecules released from platelets.

Among type, pure platelet rich plasma segment is expected to hold the dominant position, owing to the new approvals by regulatory agency. For instance, on December 1, 2019, EmCyte manufacturer of platelet rich plasma and progenitor stem cell biologics, announced that it has received U.S. food and drug association 510(k) clearance for its Progenikine Concentrating System for adipose lipoplasty. This system is designed for pure extraction centrifugation of adipose concentrates.

On the basis of applications, orthopedic surgery segment is expected to hold a dominant position over the forecast period, owning to increasing prevalence of orthopedic conditions. For instance, on August 28, 2022, an article published in cureus journal stated that Platelet-wealthy plasma (PRP) is a promising remedy alternative for more than one orthopedic conditions, which has confirmed increasing scientific use. With improved scientific use of PRP, there was an extra demand for point-of-care (POC) biologic devices.

Competitive Landscape:

Key players operating in the global platelet rich plasma market include Arthrex, Inc., Stryker Corporation, Johnson and Johnsons Ltd., Zimmer Biomet Holdings Inc., Terumo Corporation, Glofinn Oy, Medira Ltd., Regen Lab S.A., CollPlant, Generex Biotechnology Corporation, Estar Technologies Ltd., Dr. PRP America, Cesca Therapeutics, Inc., Arteriocyte Medical Systems, Harvest Technologies Corp.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/936

Market Segmentation:

  • Global Platelet Rich Plasma Market, By Type:
    • Pure PRP
    • Leukocyte rich PRP
    • Pure PRF
    • Leukocyte rich PRF
  • Global Platelet Rich Plasma Market, By Origin:
    • Autologous
    • Allogenic
    • Homologues
  • Global Platelet Rich Plasma Market, By Application:
    • Neurosurgery
    • Cosmetic Surgery
    • Orthopedic Surgery
    • General Surgery
    • Others
  • Global Platelet Rich Plasma Market, By Region:
    • North America
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Region/Country
        • South Africa
        • Central Africa
        • North Africa

Related Market Intelligence Reports:

Bovine Plasma Market, by Grade (Technical and Standard), by Origin (U.S., Australia, New Zealand, and Others (Brazil, Mexico, etc.)), by Application (Cell Culture Media, Vaccine Production, Drug Discovery, and Others (Forensic Studies, in vitro diagnostics, etc.)), by End User (Biopharmaceutical Industry, Academic & Research Institutes, and Others (Diagnostic Laboratories, Forensic Laboratories, etc.)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030

Orthopedic Regenerative Medicine Market, by Treatment Type (Stem Cell Therapy (Allogeneic Bones, Autogeneic Bones, and Bone Grafting), Plasma Based Therapy, Tissue Engineering (Allograft)), by Disease Indication (Osteoarticular Diseases, Rheumatoid Arthritis, Ligament Injuries, Bursitis, and Osteoporosis), by End User (Hospital and Clinics, Orthopedic Specialty Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2021 – 2028

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Follow Us: LinkedInTwitter

CONTACT: Mr. Shah Senior Client Partner – Business Development Coherent Market Insights Phone: US: +1-206-701-6702 UK: +44-020-8133-4027 Japan: +81-050-5539-1737 India: +91-848-285-0837 Email: [email protected] Website: https://www.coherentmarketinsights.com

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. AfternoonHeadlines.com takes no editorial responsibility for the same.